Cryo-Cell International Inc (CCEL) stock
CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 3/30
$4.15−0.02 (-0.48%)
Close on Nov 19, 2026Market cap $33.46MP/E –Yield –
Cryo-Cell International free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cryo-Cell International's free cash flow for the twelve months ending Aug 31, 2026 was $4.65M, down 24.8% year over year. For fiscal 2025 it was $5.25M, up 45.5% from the year before. Over ten years it grew 1.0% a year on average. The highest annual figure on record is $8.37M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $5.25M | +45.5% |
| FY2024 | Nov 30, 2024 | $3.61M | +73.4% |
| FY2023 | Nov 30, 2023 | $2.08M | – |
| FY2022 | Nov 30, 2022 | -$3.60M | -159.0% |
| FY2021 | Nov 30, 2021 | $6.09M | -27.2% |
| FY2020 | Nov 30, 2020 | $8.37M | +48.5% |
| FY2019 | Nov 30, 2019 | $5.63M | +15.3% |
| FY2018 | Nov 30, 2018 | $4.89M | -13.0% |
| FY2017 | Nov 30, 2017 | $5.62M | +21.0% |
| FY2016 | Nov 30, 2016 | $4.64M | -2.1% |
| FY2015 | Nov 30, 2015 | $4.74M | +230.7% |
| FY2014 | Nov 30, 2014 | $1.43M | +203.8% |
| FY2013 | Nov 30, 2013 | $472.20K | +107.7% |
| FY2012 | Nov 30, 2012 | $227.36K | -27.5% |
| FY2011 | Nov 30, 2011 | $313.41K | -83.8% |
| FY2010 | Nov 30, 2010 | $1.94M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | $1.04M | -58.4% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | $1.81M | +181.3% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | $584.76K | -34.4% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | $1.21M | -43.5% |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | $2.50M | +10.9% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | $644.61K | +2891.3% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | $892.01K | – |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | $2.15M | +31.9% |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | $2.25M | – |
| Q2 FY2024CQ2 2024 | May 31, 2024 | $21.55K | -95.9% |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | -$814.59K | -164.2% |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | $1.63M | -33.6% |
| Q3 FY2023CQ3 2023 | Aug 31, 2023 | -$1.35M | – |
| Q2 FY2023CQ2 2023 | May 31, 2023 | $531.66K | -67.6% |
| Q1 FY2023CQ1 2023 | Feb 28, 2023 | $1.27M | +47.6% |
| Q4 FY2022CQ4 2022 | Nov 30, 2022 | $2.45M | +76.9% |
| Q3 FY2022CQ3 2022 | Aug 31, 2022 | -$8.55M | -1720.1% |
| Q2 FY2022CQ2 2022 | May 31, 2022 | $1.64M | +7.4% |
| Q1 FY2022CQ1 2022 | Feb 28, 2022 | $859.12K | -67.6% |
| Q4 FY2021CQ4 2021 | Nov 30, 2021 | $1.39M | -52.6% |
| Q3 FY2021CQ3 2021 | Aug 31, 2021 | $527.74K | -74.3% |
| Q2 FY2021CQ2 2021 | May 31, 2021 | $1.53M | +96.0% |
| Q1 FY2021CQ1 2021 | Feb 28, 2021 | $2.65M | +1.6% |
| Q4 FY2020CQ4 2020 | Nov 30, 2020 | $2.93M | +202.1% |
| Q3 FY2020CQ3 2020 | Aug 31, 2020 | $2.05M | -23.8% |
| Q2 FY2020CQ2 2020 | May 31, 2020 | $778.93K | +363.9% |
| Q1 FY2020CQ1 2020 | Feb 29, 2020 | $2.61M | +44.5% |
| Q4 FY2019CQ4 2019 | Nov 30, 2019 | $969.50K | +20.3% |
| Q3 FY2019CQ3 2019 | Aug 31, 2019 | $2.69M | +3.0% |
| Q2 FY2019CQ2 2019 | May 31, 2019 | $167.90K | +424.1% |
| Q1 FY2019CQ1 2019 | Feb 28, 2019 | $1.80M | +25.5% |
| Q4 FY2018CQ4 2018 | Nov 30, 2018 | $806.12K | -61.0% |
| Q3 FY2018CQ3 2018 | Aug 31, 2018 | $2.61M | +122.5% |
| Q2 FY2018CQ2 2018 | May 31, 2018 | $32.03K | -98.4% |
| Q1 FY2018CQ1 2018 | Feb 28, 2018 | $1.44M | +237.5% |
| Q4 FY2017CQ4 2017 | Nov 30, 2017 | $2.07M | -17.9% |
| Q3 FY2017CQ3 2017 | Aug 31, 2017 | $1.17M | – |
| Q2 FY2017CQ2 2017 | May 31, 2017 | $1.95M | – |
| Q1 FY2017CQ1 2017 | Feb 28, 2017 | $426.14K | – |
| Q4 FY2016CQ4 2016 | Nov 30, 2016 | $2.52M | – |
See a number that looks wrong?